General
Preferred name
(R)-Rolipram
Synonyms
(R)-(-)-Rolipram ()
(-)-ROLIPRAM ()
P&D ID
PD006775
CAS
85416-75-7
Tags
available
drug candidate
Drug indication
Discovery agent
Drug Status
experimental
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION (R)-(-)-Rolipram is the R-enantiomer of Rolipram. Rolipram is a selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively.
PRICE 65
DESCRIPTION Potent, selective JAK3 inhibitor (Tocris Bioactive Compound Library)
DESCRIPTION PDE4 inhibitor. More active enantiomer of rolipram (Cat. No. 0905) (Tocriscreen Total)
DESCRIPTION (R)-(-)-Rolipram is a potent and cAMP-specific PDE4 inhibitor. It is 2.5-fold more potent than (+)-rolipram in inhibiting membrane-bound PDE 4. (BOC Sciences Bioactive Compounds)
DESCRIPTION PDE4 inhibitor. More active enantiomer of rolipram (Cat. No. 0905) (Tocriscreen Plus)
DESCRIPTION (R)-(-)-Rolipram ((-)-Rolipram) is an R-enantiomer of Rolipram which is a PDE4 inhibitor. (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
2
Compound Sets
13
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
DrugMAP
EUbOPEN Chemogenomics Library
MedChem Express Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
ZINC Tool Compounds
External IDs
29
Properties
(calculated by RDKit )
Molecular Weight
275.15
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
3
Aromatic Ring Count
1
cLogP
2.62
TPSA
47.56
Fraction CSP3
0.56
Chiral centers
1.0
Largest ring
6.0
QED
0.92
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Enzymes
Primary Target
Phosphodiesterases
MOA
Inhibitor
phosphodiesterase inhibitor
Target
PDE4A, PDE4B, PDE4C, PDE4D, PDE5A
PDE4 inhibitor
Phosphodiesterase (PDE)
Pathway
Metabolic Enzyme/Protease
DNA Damage/DNA Repair
PI3K/Akt/mTOR signaling
Recommended Cell Concentration
None
Source data